Precisionlife

Oxford, United Kingdom Founded: 2015 • Age: 11 yrs
AI-enabled platforms for drug discovery and precision medicine are developed.
Annual revenue - Latest available
Total funding - 2 rounds
Employees 30 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Precisionlife

Precisionlife is a company based in Oxford (United Kingdom) founded in 2015 by Gert L Moller. The company has 30 employees as of December 31, 2022. Precisionlife has completed 1 acquisition, including GenoKey. Precisionlife offers products and services including Combinatorial Analytics, DiseaseBank, and Deployment Platform. Precisionlife operates in a competitive market with competitors including Zephyr AI, Chemify, Transaction Data Systems, OpenEye Scientific and RevolKa, among others.

  • Headquarter Oxford, United Kingdom
  • Employees 30 as on 31 Dec, 2022
  • Founders Gert L Moller
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Precisionlife Ltd
  • Date of Incorporation 12 Sep, 2013
  • Jurisdiction WITNEY, OXON, ENGLAND
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    30

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Precisionlife

Precisionlife offers a comprehensive portfolio of products and services, including Combinatorial Analytics, DiseaseBank, and Deployment Platform.

Product name locked
Category locked
Primary

Analyzes disease drivers for precision medicine insights.

Product name locked
Category locked
Locked

Provides database for disease biology and patient stratification.

Product name locked
Category locked
Locked

Facilitates AI deployment for healthcare diagnostics and trials.

People of Precisionlife

Headcount 10-50
Employee Profiles 11
Employee Profiles
People
Maria Parrag, ACMA
Finance Director
People
Rowan Gardner
Chief Business and Investment Officer
People
Steve Gardner
CEO
People
Mark Strivens
Chief Technology Officer

Unlock access to complete

Funding Insights of Precisionlife

Investors in Precisionlife

Precisionlife has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Precisionlife

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Precisionlife

Precisionlife has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GenoKey.

Investments
Premium access

Investment portfolio details for Precisionlife

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of combinatorial analysis of genomic and other clinical data
Locked Locked 2010 Locked
Premium access

Complete acquisition details for Precisionlife

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Precisionlife

Premium access

Detailed financials for Precisionlife

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Precisionlife Comparisons

Precisionlife Primary company
Description
AI-enabled platforms for drug discovery and precision medici...
Location
Oxford, United Kingdom
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
30
As of 2022
Premium access

Peer comparison for Precisionlife

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Precisionlife

Precisionlife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zephyr AI, Chemify, Transaction Data Systems, OpenEye Scientific and RevolKa, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of AI development services for biopharma sector
Locked Locked Locked
Software development services are provided for pharmaceutical and materials research.
Locked Locked Locked
Software development services are provided to the biopharma sector.
Locked Locked Locked
Drug discovery and design are enabled by a cloud-based platform.
Locked Locked Locked
AI development services are provided for the biopharma sector.
Premium access

Detailed competitors of Precisionlife

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Precisionlife

Premium access

Complete news archive for Precisionlife

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Precisionlife

Precisionlife was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Precisionlife is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.

Steve Gardner is the current CEO of Precisionlife.

As of Dec 31, 2022, the latest employee count at Precisionlife is 30.

Precisionlife was founded in 2015 in Oxford, United Kingdom, focusing on the biotechnology sector. AI-driven platforms are utilized for drug discovery and precision medicine applications. Operations center on developing tools that analyze genomic data to support personalized treatments. Leadership is provided by CEO Steve Gardner and Co-Founder Gert L. Moller. Services are extended to pharmaceutical partners seeking efficient RD solutions.

Precisionlife's top competitors include Chemify, RevolKa and Zephyr AI.

Precisionlife offers Combinatorial Analytics, DiseaseBank, and Deployment Platform.

Precisionlife has made 1 acquisition, including GenoKey.

Precisionlife has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available